Screener / SEC EDGAR /CIK 0000874015 /10-K filed Feb 26, 2026, compared with Feb 19, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Ionis Pharmaceuticals Inc IONS

Compare with peers Embed
SEC comment letters, last 20 years

1 review of IONS's filings by SEC staff

UPLOAD and CORRESP
Reviews 1 latest letter Dec 30, 2020
Questions asked 2 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 1 UPLOAD
  2. 2. Questions in them 2 numbered comments
  3. 3. Company replies 1 CORRESP
  4. 4. Reviews closed 1 of 1 closing letter

Half the closed reviews took 27 days or less from the first letter to the closing letter.

Form 10-K for the Fiscal Year Ended December 31, 2019

2020-12-30 to 2021-01-26 · 2 questions · 1 letter from the SEC, 1 from the company
Review closed 2021-01-26
InventoryDerivatives and hedging
Notes to Consolidated Financial Statements
SEC asked (1)
Organization and Significant Accounting Policies Inventory Valuation, page F-19 1. Your disclosure states that inventory is reflected at the lower of cost or market value under the first-in, first-out method. Please revise your future filings to clarify, if true, that your inventory is measured at the lower of cost or net realizable value consistent with ASC 330-10-35-1B. 3. Long-Term Obligations and Commitments
IONS answered
We respectfully acknowledge the Staff’s comment and confirm that we measure our inventory at the lower of cost or net realizable value consistent with ASC 330-10-35-1B. We will revise our disclosure in future periodic reports beginning with our

2020 Form 10-K to clarify that our inventory is measured at the lower of cost or net realizable value under the first-in, first-out method.
Read in the reply
Convertible Notes and Call Spread, page F-26
SEC asked (2)
We note your disclosure concerning the call spread transaction that was entered into in conjunction with the December 2019 note exchange. You indicate that the amounts paid/received for the note hedges/warrants was recorded in additional paid-in capital.
Rest of the question

Please tell us how you determined the appropriate accounting treatment for this transaction, including your consideration of whether these financial instruments meet the definition of a derivative. Please also revise your accounting policy disclosure accordingly in future filings.

IONS answered
Long-Term Obligations and Commitments

Convertible Notes and Call Spread, page F-26

2. We note your disclosure concerning the call spread transaction that was entered into in conjunction with the December 2019 note exchange. You indicate that the amounts paid/received for the note hedges/warrants was recorded in additional paid-in capital. Please tell us how you determined the appropriate accounting treatment for this transaction, including your consideration of whether these financial instruments meet the definition of a derivative.
Rest of the answer

Please also revise your accounting policy disclosure accordingly in future filings.

We structured our response to this question using the following outline:

I.

Transaction Background

II.

Accounting Analysis

A.

Evaluation of Freestanding Financial Instruments and Units of Accounting i.

Freestanding Financial Instruments ii.

Units of Accounting

B.

Whether the note hedges and the warrants are liabilities under ASC 480

C.

Whether the note hedges and the warrants meet the conditions to be classified in equity

Note Hedges

1. Evaluation of Derivative Definition

2. Evaluation of Derivative Scope Exception

Read in the reply
In its next report

First report after the company's reply of Jan 14, 2021: 10-K filed Feb 24, 2021 ↗.

No earlier 10-K before the SEC's letter is in Tickdelta, so there is nothing to compare with.

Also in this review: closing letter, 2021-01-26

Letters without questions

Other letters

UPLOAD and CORRESP
1 other letter: notices that a filing will not be reviewed, requests to declare a registration effective, and the like

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 4 letters filed since 2020-09-24. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IONS/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.